SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-044365
Filing Date
2019-02-19
Accepted
2019-02-19 17:08:32
Documents
5
Period of Report
2019-02-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d700822d8k.htm 8-K 22167
2 EX-99.1 d700822dex991.htm EX-99.1 10958
3 EX-99.2 d700822dex992.htm EX-99.2 9143
4 GRAPHIC g700822allergan.jpg GRAPHIC 9933
5 GRAPHIC g700822g0219161819264.jpg GRAPHIC 3216
  Complete submission text file 0001193125-19-044365.txt   56742
Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Filer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36867 | Film No.: 19615911
SIC: 2834 Pharmaceutical Preparations